Casey Means and MAHA Remove the 'Public' From Public Health

On Wednesday, Donald Trump nominated Casey Means, a holistic doctor and wellness influencer, to be the next U.S. surgeon general. If confirmed, Means will be the first surgeon general who openly practices alternative medicine. She is an unusual candidate for surgeon general but an unsurprising one. Under an administration that is senselessly gutting science and research funding, "MAHA" priorities largely put the wellness dreams of the wealthy before public health.
The Office of the Surgeon General is responsible for communicating scientific information to the public and addressing public health issues. Means' record would normally be considered antagonistic toward this fundamental goal, but Trump has praised the nominee as having "impeccable 'MAHA' credentials." Means describes herself as someone who left "traditional medicine," and has expressed health beliefs that flirt with pseudoscience and closely align with those of Robert F. Kennedy Jr.
Co-author of Good Energy: The Surprising Connection Between Metabolism and Limitless Health and co-founder of Levels (a company that sells continuous glucose monitors), Means has peddled health claims that are questionable at best and dangerous at worst. Like other wellness influencers, she has dabbled in some Goop-esque activities, like consulting with a spiritual medium and taking part in a full moon ceremony, which are a little woo-woo but don't harm anyone else. Of greater consequence to public health is Means' skepticism of vaccines. She has also called birth control use "disrespect of life" and endorsed the supposed health benefits of raw milk. The prospect of having a surgeon general who believes such things is terrifying.
Beyond the pseudoscience, Means' general orientation toward health is out of touch with the needs of average Americans. She has built her career and reputation on promoting lifestyle choices such as healthy eating and exercise. From afar, her takes may appear sensible, and at times, even compatible with sound medical advice. A healthy diet and exercise are important, but they alone do not translate to good, humane policies.
Means has suggested that health issues like "depression, anxiety, infertility, heart disease, erectile dysfunction, type 2 diabetes, Alzheimer's dementia, [and] cancer" are "under our control and simpler than we think." Simpler for whom? An emphasis on lifestyle ultimately assigns structural and institutional problems to individual Americans to solve for themselves. In a country where wealth buys health, how many Americans can afford to insulate themselves and their families from risks of disease and disability? The federal minimum wage has been stagnant at $7.25 since 2009. Meanwhile, the cost of necessities like housing, food, and child care have increased precipitously.
WASHINGTON, DC - MAY 12: U.S. Health and Human Services Secretary Robert F. Kennedy Jr. speaks alongside President Donald Trump during a press conference in the Roosevelt Room of the White House on May 12,...
WASHINGTON, DC - MAY 12: U.S. Health and Human Services Secretary Robert F. Kennedy Jr. speaks alongside President Donald Trump during a press conference in the Roosevelt Room of the White House on May 12, 2025, in Washington, DC. MoreIn her "health wishlist" for the Trump administration, Means says we need leaders who will "inspire people to care about their health, the food they eat, and their fitness." Americans do not need inspiration. Americans need access. It is cruel to push the idea that people are unhealthy simply because they do not care. Our most urgent public health problems cannot be solved with personal empowerment and lifestyle choices. For instance, 7.2 million children live in food-insecure households. Meanwhile, the House of Representatives is planning to cut $12 billion from federally funded school meal programs.
Health care is also inaccessible to many Americans because, unlike many of its peer countries, the U.S. does not offer universal health coverage. Even for those who do have health insurance, coverage is often insufficient, causing many to accrue medical debt. The Trump administration has added new public health problems: the Food and Drug Administration recently suspended quality control for milk, the Department of Agriculture withdrew a proposal to reduce Salmonella in raw poultry products, and the Environmental Protection Agency has loosened restrictions on mercury pollution. Meanwhile, Kennedy continues to fuel vaccine hesitancy amid a national measles outbreak.
MAHA priorities are misaligned with public health needs. Means' sunny website—where she promotes her book, recipes, and newsletters—frames good health as an individual project. Means' wish list to the Trump administration proposes actions that would address processed foods, "Big Pharma," vaccine safety, alternative medicine, and paternalistic restrictions on SNAP. It is apparent that her and Kennedy's health concerns reflect the airy worries of the rich. Their brand of health care is for people who can choose to be healthy, people with the time and money to pursue health optimization, and people comfortable enough to be fussy over food dyes.
Pandering to the desires of the upper class, MAHA pushes products and services that are out of reach for the average American. The surgeon general is supposed to be the nation's doctor. Means is just an entrepreneur who peddles an expensive lifestyle.
Catherine Tan is an Assistant Professor in Sociology at Vassar College. She is the author of Spaces on the Spectrum: How Autism Movements Resist Experts and Create Knowledge, published by Columbia University Press.
The views expressed in this article are the writer's own.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

USA Today

an hour ago

• USA Today

When Caregiving Becomes Identity: Lynn Wenger's Real, Raw Journey Through Alzheimer's

What does it mean to love someone slowly forgetting who you are? For Lynn Wenger, the author of A Husband's Memoir: A Journey Through Alzheimer's, love wasn't just about showing up in the early days for his wife. It was about staying even when the person you knew began to fade, and every familiar rhythm was replaced with uncertainty. In the book, Lynn pulls back the curtain on a quiet transformation that took place when his wife was diagnosed with early-onset Alzheimer's at just 59 years old. He transformed from a devoted husband into a full-time caregiver, and that shift ultimately cost him. Before all this, Lynn was a self-made man from rural Iowa who built a successful career in construction consulting. Wendy was a registered nurse with a quick wit and a huge heart. She was the kind of person who showed up for her friends, volunteered at the local preschool, and still made time for church choir and book club. Together, they raised a family, built a life, and shared memories. This memoir, written in the months and years following his wife Wendy's diagnosis, isn't just about navigating the realities of Alzheimer's. It's about identity, grief, and what happens until you can't tell where love ends and caregiving begins. A Role He Never Trained For Lynn is no stranger to structure. He's a scheduler and a planner — someone who ran multi-million-dollar construction jobs with near-photographic precision. However, not even decades of professional precision or life experience could prepare him for the difficulties of caregiving. The shift from partner to caregiver was instantaneous and irreversible. Conversations grew harder. Decisions became heavier. "I wasn't just helping her," Lynn writes. "I was feeding her, dressing her, calming her down, watching for the next meltdown, trying to hold her world together while mine was quietly falling apart." The Isolation No One Sees In the outside world, Lynn kept things moving — balancing his work, organizing church events, staying involved in their local Boy Scout troop, and checking in with neighbors. But behind closed doors, life was shrinking. Time for himself became non-existent. So did the ability to sleep through the night. He wasn't just managing Wendy's care; he was carrying the emotional weight of every change. Her moods. Her confusion. Her sudden fear of water, loud noises, or unfamiliar places. Her eventual inability to recognize their own home. "There were days I couldn't even leave the room," Lynn writes. "Not because I had nowhere to go, but because she didn't want to let go of my hand." Lynn describes the kind of loneliness that only caregivers know, where you're never physically alone but constantly longing for a connection that used to be effortless. A Grief That Starts Too Soon In his reflections, Lynn speaks to a grief that begins long before a life ends. As Wendy's cognitive decline accelerated, moments of clarity became rare and precious. She could still sing along to their favorite 70s music. She could still flash her signature sense of humor. But those sparks were fleeting. "You don't just grieve the person," Lynn explains. "You grieve your life together. The future you planned. The roles you once shared." He captures the irony of being both deeply needed and gradually invisible — of loving someone who no longer knows they love you back. Regret, Real Talk, and a Little Grace Lynn's story is the unmistakable voice of a man doing his best. But also, the honesty of a man who wrestles with guilt. Guilt for the moments he spent working instead of sitting by her side. Guilt for the times he didn't recognize a symptom until it was too late. Guilt for simply needing a break. "If I could go back," he writes, "I'd trade every spreadsheet and scout meeting for one more walk around the block with her." However, Lynn doesn't let bitterness cloud his writing; he shares a unique perspective. Lynn's regrets are balanced by deep wells of grace, reminding caregivers everywhere that they're human — and doing more than enough. A Husband's Memoir: A Journey Through Alzheimer's does more than tell one couple's story. It shines a light on the hidden world of caregiving and how it involves sacrifice, resilience, humor, and heartbreak. Lynn doesn't gloss over the hard parts. Instead, he shares them so that others might feel less alone. Where Lynn Is Now Wendy passed away in early 2024 at just 64 years old. Lynn has since become an advocate for Alzheimer's awareness, supporting research and helping organize his local Walk to End Alzheimer's. He's been approached about leading support groups, especially for husbands and partners who, like him, never expected to become full-time caregivers. And he's open about the fact that he's still grieving, still figuring it all out. 'People think the hard part ends when they pass,' he says. 'But grief has its own timeline. It doesn't check your calendar.' For more information regarding Lynn and Wendy's story and to order the book, "A Husband's Memoir: A Journey Through Alzheimer's," go to: This article is for informational purposes only and does not substitute for professional medical advice. If you are seeking medical advice, diagnosis, or treatment, please consult a medical professional or healthcare provider.

New York Post

2 hours ago

• New York Post

Why Ozempic users should be extra careful during heatwaves

Talk about melting the weight off. Summer may be filled with beach days and barbecues, but it can also bring blistering temperatures. This week, millions of Americans — including New Yorkers — are bracing for what forecasters are calling a 'very sweaty' heatwave. People who are on GLP-1s need to be on particularly high alert amidst the high degrees. New Africa – And people who are on weight loss drugs like Ozempic, Wegovy and Mounjaro need to be on particularly high alert amidst the high degrees. That's because these drugs work by suppressing appetite, which means they can wind up curbing thirst as well. This, in turn, can unwittingly lead to dehydration — a dangerous condition that can cause dizziness, headaches, low blood pressure, blurred vision, kidney problems and, in extreme cases, fatal heatstroke. Since eating normally stimulates saliva flow, eating less while on Ozempic can mean less stimulation to the salivary glands, which can in turn lead to dry mouth — another symptom of dehydration left unchecked. And if you've heard about Ozempic teeth, you know some of the most common side effects of GLP-1s pose their own dangers during a heatwave. 'You'll need to be extra careful about hydration during hot weather as these medications often cause nausea, vomiting or diarrhea — all of which can lead to fluid loss,' nutritional therapist Deborah Grayson told The Daily Mail. 'This is particularly important for new users of the weight loss medication, whose bodies are still adjusting.' 'You'll need to be extra careful about hydration during hot weather as these medications often cause nausea, vomiting or diarrhea — all of which can lead to fluid loss,' Grayson said. millaf – To remain vigilant, Grayson recommends the following: Drink plenty of water, even if you don't feel thirsty Put a timer on to remind you to hydrate Avoid alcohol and caffeine Avoid being outdoors during peak heat hours Eat easy-to-digest foods such as those on the BRAT diet In addition to suppressing thirst and potentially inducing vomiting/diarrhea, GLP-1s could mess with your body's ability to regulate body temperature, making it harder to tolerate heat. This is all the more reason to drink lots of water — sprinkle some electrolytes into the mix to stay hydrated longer. Use urine as your barometer — light yellow means you're in the clear, whereas darker colors are a bad sign. And avoid physical exertion, especially outside. It might be excruciatingly hot, but perhaps the heatwave is a good excuse to stay on your Ozempic butt for a bit.

The Hill

8 hours ago

• The Hill

Thanks to imported drugs, America has lost control of its medicine cabinet

America is facing a growing crisis in its medical system — not from a lack of talent or innovation, but from a breakdown in the control, safety and supply of essential medicines. Our growing reliance on imports is now driving serious drug shortages, destabilizing supply chains and increasingly making medications unsafe. At the root of it is a hard truth: We no longer have control of the medicines we depend on every day. In 2002, America manufactured 83.7 percent of the pharmaceuticals it consumed. By 2024, that number had dropped to just 37.1 percent. Meanwhile, the U.S. pharmaceutical trade deficit has soared, reaching a record $118.3 billion in 2024. We didn't just outsource manufacturing — we outsourced the sovereignty and safety of our health care system. This means that nearly two-thirds of America's pharmaceutical supplies are now imported. Most critical medications, such as generic drugs, now come from China and India. China controls 80 to 90 percent of the global supply of active pharmaceutical ingredients — the chemical building blocks of modern medicine. Even drugs labeled 'Made in the USA' often chemically originate in China. And India, which produces about half of America's finished generic drugs, relies on China for up to 80 percent of its active pharmaceutical not a supply chain — it's a ticking time something goes wrong, American patients suffer. In 2023, the Food and Drug Administration shut down a single Indian plant responsible for 50 percent of the U.S. supply of cisplatin, a critical chemotherapy drug, after uncovering a 'cascade of failure' in safety practices and shredded documents soaked in acid. With no domestic backup, patients nationwide had their treatments delayed. That wasn't a fluke. 40 percent of U.S. generic drugs have only one FDA-approved manufacturer. Because of that single chokepoint, when one factory fails, the whole system can crack. We are now seeing widespread drug shortages across the medical system. Hospital pharmacists report an average of 301 critical drug shortages at any given time. And 85 percent say these shortages are moderately or critically affecting care. Doctors often lack crucial medicines such as antibiotics, sedatives and cancer drugs. These aren't obscure drugs. They're foundational medicines. But America no longer makes them. Even when imported drugs do arrive, they're not always safe. A 2025 study found that Indian generics are 54 percent more likely to cause serious side effects than their U.S.-made counterparts. Indian factory violations have also been tied to at least eight U.S. patient deaths. China's record is equally disturbing. In 2008, dozens of Americans died after receiving contaminated heparin from Chinese suppliers. This isn't what the American people want. In a national survey, 85 percent of hospital pharmacists said they would pay more for safer generics. But under today's rules, price overshadows quality. Hospitals have little oversight of drug quality — and foreign producers face few consequences for cutting corners. Even the federal government is flying blind. A 2023 Department of Defense review found that 22 percent of essential military-use drugs had unknown ingredient sourcing. That's a national security April, the Trump administration took a necessary step by launching an investigation into generic pharmaceutical imports that correctly frames the issue as a national security threat. But that recognition alone isn't enough. To address this crisis, Washington should impose targeted tariffs on generic drugs from adversarial nations. It must also rebuild domestic pharmaceutical production through tax credits and long-term contracts. America urgently needs full transparency in drug labeling to disclose where drugs and their ingredients are made. The FDA must step up — with stronger enforcement abroad and a ban on imports from repeat safety violators. And to secure critical ingredients during market disruptions, Washington must pursue a long-term vision that includes a 'strategic pharmaceutical reserve.' This isn't just protectionism. It's a restoration of America's medical security. No nation can call itself sovereign if it can't produce its own medicines, and no patient is safe if their health care depends on quality control in a factory 8,000 miles decades, we were told that offshoring production would make things cheaper, smoother and more efficient. But America can no longer depend on unstable foreign suppliers. It's time to restore our pharmaceutical independence and take back control of our medicine cabinet. Andrew Rechenberg is an economist at the Coalition for a Prosperous America.